Abstract
Myth or Real? The Potential Serious Side Effects of Ticagrelor
Ticagrelor, a novel direct, reversibly binding P2Y12 antagonist, has better pharmacodynamic effects and improves clinical outcomes compared with clopidogrel in the setting of ACS. However, ticagrelor-related dyspnea and bradyarrhythmias have been observed in the PLATO trial, here in my case I will present a case of ticagrelor side effects and how it may burden the course of hospital stay.
Author(s):
Wassam EL Din Hadad EL Shafey
Abstract | Full-Text | PDF
Share this
Awards Nomination
Abstracted/Indexed in
- Google Scholar
- Genamics JournalSeek
- CiteFactor
- Directory of Research Journal Indexing (DRJI)
- WorldCat
- Proquest Summons
- Secret Search Engine Labs
Open Access Journals
- Aquaculture & Veterinary Science
- Chemistry & Chemical Sciences
- Clinical Sciences
- Engineering
- General Science
- Genetics & Molecular Biology
- Health Care & Nursing
- Immunology & Microbiology
- Materials Science
- Mathematics & Physics
- Medical Sciences
- Neurology & Psychiatry
- Oncology & Cancer Science
- Pharmaceutical Sciences